US drug giant Pfizer has declared it is focused on existing vaccine manufacturing sites in North America and Europe, dampening hopes that Australia could set up manufacturing of its COVID-19 shot in the short-term.
“We have confidence in our ability to quickly scale and manufacture large quantities of a high-quality COVID-19 vaccine, using multiple manufacturing sites in the US and Europe,” she said. Australia now has 40 million doses of Pfizer’s vaccine on order and doses are expected between now and the end of 2021.
CSL’s chief scientific officer Andrew Nash said the company welcomed the Victorian government’s announcement on mRNA and looked “forward to hearing more about the proposal and how industry might contribute”.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: